Skip to content
10-Q

Quarterly Report

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

0001493152-24-021937

← back to feed
Filed
May 30, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 30, 2024 4.59B sh
Shares Diluted Q1 2024 · Mar 31, 2024 3.95B sh
Shares Diluted Q1 2024 · Mar 31, 2023 2.69B sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$205.51K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$201.08K
Cash And Equivalents Q1 2024 · Mar 31, 2024 $53.48K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $27.82K
Cash And Equivalents Q1 2024 · Mar 31, 2023 $18.53K
Stockholders Equity Q1 2024 · Mar 31, 2024 $1.41M
Stockholders Equity Q1 2024 · Dec 31, 2023 $1.13M
Current Liabilities Q1 2024 · Mar 31, 2024 $1.95M
Current Liabilities Q1 2024 · Dec 31, 2023 $1.9M
Total Liabilities Q1 2024 · Mar 31, 2024 $2.04M
Total Liabilities Q1 2024 · Dec 31, 2023 $2.01M
Current Assets Q1 2024 · Mar 31, 2024 $924.3K
Current Assets Q1 2024 · Dec 31, 2023 $85.91K
Total Assets Q1 2024 · Mar 31, 2024 $4.05M
Total Assets Q1 2024 · Dec 31, 2023 $3.29M
Eps Diluted Q1 2024 · Mar 31, 2024 $0.00
Eps Diluted Q1 2024 · Mar 31, 2023 $0.00
Eps Basic Q1 2024 · Mar 31, 2024 $0.00
Eps Basic Q1 2024 · Mar 31, 2023 $0.00
Rd Expense Q1 2024 · Mar 31, 2024 $58.61K
Rd Expense Q1 2024 · Mar 31, 2023 $52.73K
Net Income Q1 2024 · Mar 31, 2024 −$585.14K
Net Income Q1 2024 · Mar 31, 2023 −$577.88K
Operating Income Q1 2024 · Mar 31, 2024 −$673.24K
Operating Income Q1 2024 · Mar 31, 2023 −$429.87K
Gross Profit Q1 2024 · Mar 31, 2024 $14.32K
Gross Profit Q1 2024 · Mar 31, 2023 $14.66K
Cost Of Revenue Q1 2024 · Mar 31, 2024 $7.49K
Cost Of Revenue Q1 2024 · Mar 31, 2023 $8.47K
Revenue Q1 2024 · Mar 31, 2024 $21.81K
Revenue Q1 2024 · Mar 31, 2023 $23.12K